129 related articles for article (PubMed ID: 9893663)
1. Vincristine- and cisplatin-induced apoptosis in human retinoblastoma. Potentiation by sodium butyrate.
Conway RM; Madigan MC; Billson FA; Penfold PL
Eur J Cancer; 1998 Oct; 34(11):1741-8. PubMed ID: 9893663
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Sreenivasan S; Krishnakumar S
Curr Eye Res; 2015; 40(11):1153-65. PubMed ID: 25495096
[TBL] [Abstract][Full Text] [Related]
3. Low concentrations of chloroquine and 3-methyladenine suppress the viability of retinoblastoma cells synergistically with vincristine independent of autophagy inhibition.
Zheng XY; Li LJ; Li W; Jiang PF; Shen HQ; Chen YH; Chen X
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2309-15. PubMed ID: 26335535
[TBL] [Abstract][Full Text] [Related]
4. Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells.
Lauricella M; Giuliano M; Emanuele S; Vento R; Tesoriere G
Tumour Biol; 1998; 19(5):356-63. PubMed ID: 9701726
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of TMPyP4 interacting G-quadruplex in retinoblastoma cell lines.
Mikami-Terao Y; Akiyama M; Yuza Y; Yanagisawa T; Yamada O; Kawano T; Agawa M; Ida H; Yamada H
Exp Eye Res; 2009 Aug; 89(2):200-8. PubMed ID: 19328784
[TBL] [Abstract][Full Text] [Related]
6. miR-130a-3p Enhances the Chemosensitivity of Y79 Retinoblastoma Cells to Vincristine by Targeting PAX6 Expression.
Lu X; Tu H; Tang D; Huang X; Sun F
Curr Eye Res; 2022 Mar; 47(3):418-425. PubMed ID: 34547965
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis in human retinoblastoma cells by topoisomerase inhibitors.
Giuliano M; Lauricella M; Vassallo E; Carabillò M; Vento R; Tesoriere G
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1300-11. PubMed ID: 9660477
[TBL] [Abstract][Full Text] [Related]
9. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis by sodium butyrate in the human Y-79 retinoblastoma cell line.
Conway RM; Madigan MC; Penfold PL; Billson FA
Oncol Res; 1995; 7(6):289-97. PubMed ID: 8527863
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy for retinoblastoma.
Chan HS; Gallie BL; Munier FL; Beck Popovic M
Ophthalmol Clin North Am; 2005 Mar; 18(1):55-63, viii. PubMed ID: 15763191
[TBL] [Abstract][Full Text] [Related]
12. Synergistic cytotoxic interactions between sodium butyrate, MG132 and camptothecin in human retinoblastoma Y79 cells.
Lauricella M; Calvaruso G; Giuliano M; Carabillò M; Emanuele S; Vento R; Tesoriere G
Tumour Biol; 2000; 21(6):337-48. PubMed ID: 11006574
[TBL] [Abstract][Full Text] [Related]
13. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
[TBL] [Abstract][Full Text] [Related]
15. Cytokine induced apoptosis in human retinoblastoma cells.
Cullinan AE; Brandt CR
Mol Vis; 2004 Apr; 10():315-22. PubMed ID: 15133451
[TBL] [Abstract][Full Text] [Related]
16. 1,25-dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax.
Wagner N; Wagner KD; Schley G; Badiali L; Theres H; Scholz H
Exp Eye Res; 2003 Jul; 77(1):1-9. PubMed ID: 12823982
[TBL] [Abstract][Full Text] [Related]
17. Revisiting old drugs as novel agents for retinoblastoma: in vitro and in vivo antitumor activity of cardenolides.
Antczak C; Kloepping C; Radu C; Genski T; Müller-Kuhrt L; Siems K; de Stanchina E; Abramson DH; Djaballah H
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3065-73. PubMed ID: 19151399
[TBL] [Abstract][Full Text] [Related]
18. Characterization of etoposide- and cisplatin-chemoresistant retinoblastoma cell lines.
Busch M; Papior D; Stephan H; Dünker N
Oncol Rep; 2018 Jan; 39(1):160-172. PubMed ID: 29192327
[TBL] [Abstract][Full Text] [Related]
19. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
20. The apoptotic effects of cisplatin and carboplatin in retinoblastoma Y79 cells.
Di Felice V; Lauricella M; Giuliano M; Emanuele S; Vento R; Tesoriere G
Int J Oncol; 1998 Aug; 13(2):225-32. PubMed ID: 9664115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]